Michael W.M. Kühn, Scott A. Armstrong Cancer Cell

Slides:

Advertisements

Similar presentations

Individualized Medicine from Prewomb to Tomb Eric J. Topol Cell Volume 157, Issue 1, Pages (March 2014) DOI: /j.cell Copyright.

Advertisements

What We Talk About When We Talk About Fat Evan D. Rosen, Bruce M. Spiegelman Cell Volume 156, Issue 1, Pages (January 2014) DOI: /j.cell

Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr

Distribution of Human Embryonic Stem Cell Lines: Who, When, and Where Jennifer B. McCormick, Jason Owen-Smith, Christopher Thomas Scott Cell Stem Cell.

Eph-Ephrin Bidirectional Signaling in Physiology and Disease Elena B. Pasquale Cell Volume 133, Issue 1, Pages (April 2008) DOI: /j.cell

Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem

Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia Tim C.P. Somervaille, Michael L. Cleary Cancer Cell.

Module Map of Stem Cell Genes Guides Creation of Epithelial Cancer Stem Cells David J. Wong, Helen Liu, Todd W. Ridky, David Cassarino, Eran Segal, Howard.

Human Brown Adipose Tissue Sven Enerbäck Cell Metabolism Volume 11, Issue 4, Pages (April 2010) DOI: /j.cmet Copyright © 2010.

The Metabolic Basis of Pulmonary Arterial Hypertension Gopinath Sutendra, Evangelos D. Michelakis Cell Metabolism Volume 19, Issue 4, Pages (April.

Hedgehog Signaling Restrains Bladder Cancer Progression by Eliciting Stromal Production of Urothelial Differentiation Factors Kunyoo Shin, Agnes Lim, Chen.

Normal and Leukemic Stem Cell Niches: Insights and Therapeutic Opportunities Koen Schepers, Timothy B. Campbell, Emmanuelle Passegué Cell Stem Cell Volume.

T-ALL: Home Is where the CXCL12 Is

A Novel Link between Inflammation and Cancer

Kicking Genomic Profiling to the Curb: How Re-wiring the Phosphoproteome Can Explain Treatment Resistance in Glioma Fred C. Lam, Michael B. Yaffe Cancer.

Cancer: Inappropriate Expression of Stem Cell Programs?

Building better therapy for children with acute lymphoblastic leukemia

NF-κB: A Coordinator for Epigenetic Regulation by MLL

Genomic Dark Matter Sheds Light on EVI1-Driven Leukemia

Linking miRNA Regulation to BCR-ABL Expression: The Next Dimension

Scratching the Surface of Immunotherapeutic Targets in Neuroblastoma

Intravascular Survival and Extravasation of Tumor Cells

Kenneth L. Scott, Scott Powers Cancer Cell

Christopher J. Pirozzi, Zachary J. Reitman, Hai Yan Cancer Cell

An Alternative Sugar Fuels AML

NAD+ Supplementation as a Novel Approach to cURIng HCC?

A Path to Insulin Independence: “The End of the Beginning”

RNase E Finds Some sRNAs Stimulating

Gerard L. Brien, Daria G. Valerio, Scott A. Armstrong Cancer Cell

Bernd B. Zeisig, Ngai Cheung, Jenny Yeung, Chi Wai Eric So Cancer Cell

Michael W.M. Kühn, Scott A. Armstrong Cancer Cell

CALming Down T Cell Acute Leukemia

Scratching the Surface of Immunotherapeutic Targets in Neuroblastoma

Alyson A. Lokken, Nancy J. Zeleznik-Le Cancer Cell

Regulating Cancer Stem Cells the miR Way

Can Treating the SYK Cell Cure Leukemia?

Pontine Infantile Glioma Simplified

CALming Down T Cell Acute Leukemia

Unraveling the Pros and Cons of Interferon-γ Gene Regulation

New Views into the Genetic Landscape of Metastatic Breast Cancer

The Case of the Disappearing Drug Target

Coordinate Transcriptional Regulation by ERG and Androgen Receptor in Fusion- Positive Prostate Cancers Yu Chen, Charles L. Sawyers Cancer Cell Volume.

Gliomas “Dope Up” for Growth

MicroRNAs and Parallel Stem Cell Lives

The p27Kip1 tumor suppressor gene: Still a suspect or proven guilty?

Volume 20, Issue 1, Pages 3-5 (July 2011)

A MENage à Trois in Leukemia

Targeting β-catenin in CML: Leukemia Stem Cells Beware!

Distinct pathways affected by menin versus MLL1/MLL2 in MLL-rearranged acute myeloid leukemia Yufei Chen, Kenneth L. Jones, Konstantinos Anastassiadis,

MicroRNAs: From Decay to Decoy

Drugging Chromatin in Cancer: Recent Advances and Novel Approaches

Meddling with METTLs in Normal and Leukemia Stem Cells

Kenneth L. Scott, Scott Powers Cancer Cell

Volume 49, Issue 1, Pages 1-3 (January 2013)

aSIRTing Control over Cancer Stem Cells

Volume 14, Issue 4, Pages (October 2008)

Wilbert Bitter, Coen Kuijl Cell Host & Microbe

Genome-Wide SNP Analysis in Cancer: Leukemia Shows the Way

RIPK3 Slams the Brake on Leukemogenesis

Splicing and Dicing MYC-Mediated Synthetic Lethality

TFIID and MYB Share a Therapeutic Handshake in AML

Glycogen Synthase Kinase-3 and Cancer: Good Cop, Bad Cop?

c-Raf in KRas Mutant Cancers: A Moving Target

The Tribble with APL: A New Road to Therapy

Volume 12, Issue 6, Pages (December 2007)

Long Noncoding RNAs in Cancer Pathways

In This Issue Cell Volume 145, Issue 3, (April 2011)

Christopher G. Abraham, Joaquín M. Espinosa Cancer Cell

Targeting Protein Stability with a Small Molecule

Tackling Resistance to PI3K Inhibition by Targeting the Epigenome

Presentation transcript:

Designed to Kill: Novel Menin-MLL Inhibitors Target MLL-Rearranged Leukemia Michael W.M. Kühn, Scott A. Armstrong Cancer Cell Volume 27, Issue 4, Pages 431-433 (April 2015) DOI: 10.1016/j.ccell.2015.03.012 Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 1 Inhibiting the Menin-MLL Interaction Causes Hox Gene Downregulation and Differentiation of MLL-Rearranged Leukemia (A) The menin-MLL interaction is required for Hox gene expression that is critical for MLL-rearranged leukemia. (B) Small-molecule MI-463 and MI-503 block the MLL binding site on menin, resulting in downregulation of Hox genes and differentiation of leukemic blasts. Cancer Cell 2015 27, 431-433DOI: (10.1016/j.ccell.2015.03.012) Copyright © 2015 Elsevier Inc. Terms and Conditions